Effects of single bolus dose of intravenous Dexmedetomidine on intrathecal hyperbaric Bupivacaine: a randomized double blind placebo controlled trial

Authors

  • Manjunath Reddy The Bangalore Hospital, RV Road, Bangalore 560004, Karnataka
  • Archana Byadarahalli Narayanappa Mandya Institute of Medical Sciences, Mandya, Karnataka 571401
  • Sreenivasa Babu The Bangalore Hospital, RV Road, Bangalore 560004, Karnataka

Keywords:

Bupivacaine, Dexmedetomidine, Spinal anaesthesia

Abstract

Background: To prolong the effect of spinal anaesthesia into the postoperative period many pharmacological agents are being used intrathecally and intravenously. The present study was designed to assess the effects of single bolus dose of intravenous Dexmedetomidine on spinal anaesthesia and analgesia in patients undergoing lower abdominal surgeries under spinal anaesthesia with 0.5% Hyperbaric Bupivacaine.

Methods: One hundred patients posted for lower abdominal surgeries under spinal anaesthesia were randomly allocated to two groups. Group D (study group) patients received single bolus dose of 0.5mcg/kg of intravenous Dexmedetomidine and Group C (control group) received 10ml of normal saline. Variation in the onset, duration of sensory and motor level, duration of analgesia, effect on sedation and side effects were recorded.

Results: The duration of sensory block and two segment regression was significantly prolonged in Group D (189.90+-7.66 minutes, 104+-20.6 minutes) as compared to Group C (145.60+-11.98 minutes, 75+-22.5 minutes) respectively. The onset of sensory block was earlier in Group D then compared to Group C which was statistically significant. The duration of analgesia in Group D (218.8+-11.36 minutes) was prolonged when compared to Group C (178.6+-17.96 minutes). Sedation score and incidence of bradycardia was high in Group D when compared to Group C.

Conclusion: Single bolus dose of IV Dexmedetomidine prior to spinal anaesthesia prolongs the duration of sensory block and duration of analgesia with satisfactory arousable sedation and acceptable side effects.

References

1. Dobrydnjov I, Axelsson K, Thorn SE, Matthiesen P, Klockhoff H, Holmstorm B, et al. Clonidine combined with small dose bupivacaine during spinal anesthesia for inguinal herniorrhaphy: A randomized double blinded study. Anesth Analg 2003;96:1496-503.
http://dx.doi.org/10.1213/01.ANE.0000061110.62841.E9
[PMID:12707157]
2. Rhee K, Kang K, Kim J, Jeon Y. Intravenous clonidine prolongs, bupivacaine spinal anesthesia. Acta Anaesthesiol Scand 2003;47:1001-5.
http://dx.doi.org/10.1034/j.1399-6576.2003.00158.x
[PMID:12904193]
3. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705.
http://dx.doi.org/10.1097/00000539-200003000-00035
[PMID:10702460]
4. Kamibayashi T, Maze M. Clinical uses of alpha 2-adrenergic agonists. Anesthesiology 2000;93:1345-9.
http://dx.doi.org/10.1097/00000542-200011000-00030
[PMID:11046225]
5. Lugo VW, Gomez IA, Cisneros-Corral R, Martinez-Gallegos N. Intravenous dexmedetomidine versus intravenous clonidine to prolong bupivacaine spinal anaesthesia. A double blind study. Anestesia en Mexico 2007;19:143-6.
6. Al-Mustafa MM, Badran IZ, Abu-Ali HM, Al-Barazangi BA, Massad IM, Al-Ghanem SM. Intravenous dexmedetomidine prolongs bupivacaine spinal analgesia. Middle East J Anesthesiol 2009;20:225-31.
[PMID:19583070]
7. Harsoor SS, Rani DD, Yalamuru B, Sudheesh K, Nethra SS. Effect of supplementation of low dose intravenous dexmedetomidine on characteristics of spinal anaesthesia with hyperbaric bupivacaine. Indian J Anaesth 2013;57:265-9.
http://dx.doi.org/10.4103/0019-5049.115616
[PMID:23983285] [PMCID:PMC3748681]
8. Khan ZP, Ferguson CN, Jones RM. Alpha‐2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999;54:146-65.
http://dx.doi.org/10.1046/j.1365-2044.1999.00659.x
[PMID:10215710]
9. Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: A review of clinical applications. Curr Opin Anaesthesiol 2008;21:457-61.
http://dx.doi.org/10.1097/ACO.0b013e328305e3ef
[PMID:18660652]
10. Shukry M, Miller JA. Update on dexmedetomidine: Use in non intubated patients requiring sedation for surgical procedures. Ther Clin Risk Manag 2010;6:111-21.
http://dx.doi.org/10.2147/TCRM.S5374
[PMID:20421911] [PMCID:PMC2857611]
11. Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD, Alameddine MM, Al-Yaman R, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand 2006;50:222-7.
http://dx.doi.org/10.1111/j.1399-6576.2006.00919.x
[PMID:16430546]
12. Aantaa RE, Unto JH, Scheinin M, Kallio AM, Scheinin H. Dexmedetomidine premedication for minor gynecologic surgery. Anesth Analg 1990;70:407-13.
http://dx.doi.org/10.1213/00000539-199004000-00011
[PMID:1969252]
13. Jaakola ML, Salonen M, Lehtinen R, Scheinin H. The analgesic action of dexmedetomidine-a novel α2 -adrenoceptor agonist-in healthy volunteers. Pain 1991;46:281-5.
http://dx.doi.org/10.1016/0304-3959(91)90111-A
[PMID: 1684653]
14. Jorm CM, Stamford JA. Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus ceruleus slices. Br J Anaesth 1993;71:447-9.
http://dx.doi.org/10.1093/bja/71.3.447
[PMID:8104450]
15. Guo TZ, Buttermann AE, Jiang JY, Maze M. Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology 1996;84:873-81.
http://dx.doi.org/10.1097/00000542-199604000-00015
[PMID:8638842]
16. Kaya FN, Yavascaoglu B, Turker G, Yildirim A, Gurbet A, Mogol EB, Ozcan B. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia. Can J Anesth 2010;57:39-45.
http://dx.doi.org/10.1007/s12630-009-9231-6
[PMID:20039221]
17. Reddy VS, Shaik NA, Donthu B, Sannala VK,Jangam V. Intravenous dexmedetomidine versus clonidine for prolongation of bupivacaine spinal anesthesia and analgesia: A randomized double-blind study. J Anaesthesiol Clin Pharmacol 2013;29:342-7.
http://dx.doi.org/10.4103/0970-9185.117101
[PMID:24106359] [PMCID:PMC3788233]
18. Jung SH, Lee SK, Lim KJ, Park EY, Kang MH, Lee JM, Hong SJ. The effects of single-dose intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia. J Anaesth 2013;27:380-4.
http://dx.doi.org/10.1007/s00540-012-1541-0
[PMID:23307164]
19. Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 2002;95:461-6.
http://dx.doi.org/10.1097/00000539-200208000-00042
[PMID:12145072]
20. Aantaa R, Jaakola ML, Kallio A, Et Kanto J, Scheinin M, Vuorinen J. A comparison of dexmedetomidine, and α2- adrenoceptor agonist and midazolam as intramuscular premedication for minor gynaecological surgery. Br J Anaesth 1991;67:402-9.
http://dx.doi.org/10.1093/bja/67.4.402
[PMID:1681840]
21. Scheinin H, Karhuvaara S, Olkkola KT. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther 1992;52:537-46.
http://dx.doi.org/10.1038/clpt.1992.182
[PMID:1358496]
22. Virkkila M, Ali-Melkkila T, Kanto J, Scheinin H. Dexmedetomidine as intramuscular premedication for daycase cataract surgery. A comparative study of dexmedetomidine, midazolam and placebo. Anaesthesia 1994;49:853-8.
http://dx.doi.org/10.1111/j.1365-2044.1994.tb04257.x
[PMID:7802178]

Downloads

Published

2016-03-20

How to Cite

Reddy, M., Narayanappa, A. B., & Babu, S. (2016). Effects of single bolus dose of intravenous Dexmedetomidine on intrathecal hyperbaric Bupivacaine: a randomized double blind placebo controlled trial. Journal of Society of Anesthesiologists of Nepal, 3(1), 8-12. Retrieved from http://www.jsan.org.np/jsan/index.php/jsan/article/view/103

Issue

Vol. 3 No. 1 (2016): 2016 March Issue

Section

Original Article

License

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.